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Neutrophils induce macrophage anti-
inflammatory reprogramming by
suppressing NF-κB activation
John A. Marwick1, Ross Mills1, Oliver Kay1, Kyriakos Michail1, Jillian Stephen2, Adriano G. Rossi1, Ian Dransfield1 and
Nikhil Hirani1
Abstract
Apoptotic cells modulate the function of macrophages to control and resolve inflammation. Here, we show that
neutrophils induce a rapid and sustained suppression of NF-κB signalling in the macrophage through a unique
regulatory relationship which is independent of apoptosis. The reduction of macrophage NF-κB activation occurs
through a blockade in transforming growth factor β-activated kinase 1 (TAK1) and IKKβ activation. As a consequence,
NF-κB (p65) phosphorylation is reduced, its translocation to the nucleus is inhibited and NF-κB-mediated inflammatory
cytokine transcription is suppressed. Gene Set Enrichment Analysis reveals that this suppression of NF-κB activation is
not restricted to post-translational modifications of the canonical NF-κB pathway, but is also imprinted at the
transcriptional level. Thus neutrophils exert a sustained anti-inflammatory phenotypic reprogramming of the
macrophage, which is reflected by the sustained reduction in the release of pro- but not anti- inflammatory cytokines
from the macrophage. Together, our findings identify a novel apoptosis-independent mechanism by which
neutrophils regulate the mediator profile and reprogramming of monocytes/macrophages, representing an important
nodal point for inflammatory control.
Neutrophils were once thought to be relatively mono-
functional cells, with a role comprising of an early
recruitment to the site of injury to kill and remove
infectious agents. However, the diversity of their immu-
nomodulatory functions has become increasingly appar-
ent1, particularly through apoptosis which provides a
powerful anti-inflammatory signal2. The most intensely
studied anti-inflammatory action of apoptotic neutrophils
is the interaction with macrophages, in which the mac-
rophage mediator profile switches from pro- to anti-
inflammatory3,4. The resultant suppression of inflamma-
tory cytokines such as TNF and CXCL-84 and increased
negative/positive feedback loops from anti-inflammatory
mediators, including TGFβ5, IL-106 and Resolvins7 are
pivotal in driving an anti-inflammatory/pro-resolving
microenvironment that favours tissue repair8. More
recent studies have shown that viable neutrophils also
modulate the inflammatory actions of surrounding cells
through the release of microvesicles9. The potential for
neutrophils to exert control of macrophage inflammatory
functions independently of apoptosis suggests a unique
relationship where, far from being functionally limited,
neutrophils form an integral part of the mechanism for
control of inflammation. However, our understanding of
the intracellular signalling that neutrophils elicit in mac-
rophages remains unclear and is confounded by a lack of a
direct comparison between the immunomodulatory
effects mediated by apoptotic and viable neutrophils.
NF-κB is a key regulator of inflammatory signalling10
and an important molecular determinant of macrophage
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phenotype through induction of inflammatory mediators
including TNF, IL-6, CXCL-8, IL-1β, IL-12 and COX11.
Studies focusing on the effect of apoptotic neutrophils
show a reduction in TLR4-induced release of inflamma-
tory cytokines from macrophages (e.g., TNF and CXCL-
8)4. This implicates an involvement of NF-κB, which is
activated through canonical TLR4 signalling to facilitate
the transcription of inflammatory mediators such as TNF
and CXCL-810,11. However, a direct involvement for NF-
κB has not been demonstrated. Studies using murine
macrophage cell lines co-cultured with apoptotic cell
targets have suggested that although DNA binding of NF-
κB is unaffected12, the transcriptional activity of NF-κB
sites is reduced indirectly through interference with a
common transcriptional co-activator such as CBP or
p30013. However, there are no studies relating to whether
viable and apoptotic neutrophils exert distinct effects on
NF-κB activation to modulate macrophage mediator
profiles and whether these regulatory mechanisms are
present in human cells. In this study, we use primary
human cells to address the key questions of whether
neutrophils modulate the inflammatory signalling of
macrophages by suppressing NF-κB activation and whe-
ther this modulation differs once the apoptotic program is
engaged.
Results
Apoptotic and viable neutrophils induce a near identical
change in the cytokine profile released by macrophages
Firstly, we sought to address the question of whether the
LPS-induced macrophage cytokine profile was modulated
by co-culture with either viable or apoptotic neutrophils
and, if so, whether they exert differential effects? We
measured the release of TNF induced by LPS from human
monocyte-derived macrophages (MDMs) which were co-
cultured for 6 h with either viable or apoptotic popula-
tions from three distinct human immune cell lineages;
blood neutrophils, T cells (Jurkat cell line) and B cells
(BL-2 cell line). Co-culture of MDM with apoptotic cells
significantly reduced the release of TNF from the MDMs,
regardless of cell lineage (Fig. 1a). In contrast, only viable
neutrophils significantly reduced the release of TNF when
co-cultured with MDM (Fig. 1a). Importantly, the potency
of the suppression induced by viable neutrophils was
similar to that induced by apoptotic neutrophils (Fig. 1b).
We extended our analysis to include blood monocytes,
inflammatory (IFN-γ) primed MDMs and primary human
alveolar macrophages (Fig. 1c), all of which showed a
reduction in LPS-induced TNF release when co-cultured
in the presence of either viable or apoptotic neutrophils.
Thus, the suppression of TNF release induced by viable
and apoptotic neutrophils was not restricted to a parti-
cular monocyte/macrophage differentiation/activation
status. To exclude the possibility that these observations
reflected a unique property of blood neutrophils, we next
co-cultured monocytes and MDMs with viable neu-
trophils isolated from the bronchoalveolar lavage (BAL) of
patients with lung inflammation which represent a true
activated neutrophil from a site of inflammation. In these
experiments, the lung neutrophils (>97% viable) were
found to induce the same suppressive effects on monocyte
and macrophage TNF release (Fig. 1d), confirming the
potential for viable neutrophils to modulate cytokine
production at an inflammatory site and the validity of
using blood neutrophils.
Comparison of the spectrum of changes to the MDM
cytokine profile following co-culture with apoptotic
(Fig. 1e–i) or viable neutrophils (Fig. 1e–ii), revealed a
common pattern; the release of inflammatory cytokines
such as TNF, CXCL-8 and CCL-2 were suppressed, whilst
the release of anti-inflammatory cytokines such as IL-10,
IL-1ra and TGFβ were either unchanged or elevated. The
near identical alterations to MDM cytokine profile
induced by viable and apoptotic neutrophils raised the
question of whether the presence of residual viable cells in
the apoptotic neutrophil preparations could account for
these results. Highly purified apoptotic neutrophil popu-
lations (isolated by cell sorting and containing <1% viable
neutrophils; Fig. 1f) were highly effective at reducing the
release of TNF from LPS-stimulated MDMs, definitively
demonstrating that apoptotic neutrophils alone were
capable of modulating macrophage cytokine production
(Fig. 1f). Conversely, we found that <2% of the neutrophil
population underwent apoptosis, as assessed by caspase
3/7 activation and staining for annexin V and propidium
iodide (Fig. 1g) during the 6 h co-culture period. At the
neutrophil to MDM ratio of 3:1 used in these experi-
ments, the effective ratio of apoptotic neutrophils to
MDMs would be equivalent to 1:16.7 which we have
shown is too low to suppress MDM cytokine production
(Fig. 1b). These data definitively demonstrate that the
modulation of the LPS-induced cytokine profile of
monocyte/macrophage by neutrophils is independent of
apoptosis.
Neutrophils suppress inflammatory macrophage cytokine
production in response to TLR4, TNFR1 and IL-1R ligands
Our demonstration that both apoptotic and viable
neutrophils induce a common suppression of LPS-
induced cytokine release from MDM raised the question
as to whether this effect was specific to TLR4-mediated
signalling or extended to other inflammatory signalling
pathways. The issue of specificity is physiologically
important, as suppression of a broad spectrum of
inflammatory signalling pathways would exert effective
control of macrophage cytokine production at an
inflammatory site. We therefore tested the effects of
neutrophil co-culture on two distinct receptor pathways
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Fig. 1 Neutrophil-mediated changes to the macrophage inflammatory cytokine profile. a LPS-induced (1 ng/ml; 6 h) TNF release from MDM
co-cultured with viable and apoptotic BL-2 cells, Jurkat cells (both n= 6) and neutrophils (n= 10). b LPS-induced (1 ng/ml; 6 h) TNF release from
co-cultures of MDM with apoptotic (closed bars) and viable (open bars) neutrophils at the ratio of neutrophil to MDM as indicated (n= 4).
c LPS-induced (1 ng/ml; 6 h) TNF release from monocytes (n= 12), INFγ (20 ng/ml) primed MDM (n= 6) and alveolar macrophages (n= 11) co-
cultured with apoptotic or viable neutrophils. d LPS-induced (1 ng/ml; 6 h) TNF release from MDM and monocytes co-cultured with neutrophils
isolated from BAL (n= 4): cytocentrifugation preparation of BAL neutrophils stained with Diff-Quik shows the multi-lobed morphology of viable
neutrophils, cells stained pink are eosinophils. Flow cytometry of BAL neutrophils stained with annexin V and propidium iodide where the upper left
quadrant represents cell debris, the upper right quadrant represents necrotic cells, the lower right quadrant represents apoptotic cells and the lower
left represents viable cells. e LPS-induced (1 ng/ml; 6 h) cytokine profiles from MDM co-cultured with apoptotic (i) and viable (ii) neutrophils (n= 6-
12). f Basal and LPS-induced (1 ng/ml; 6 h) TNF release from MDM co-cultured with apoptotic neutrophils purified by cell sorting annexin
V+/propidium iodide- cells (n= 7). Neutrophils are negative for bound annexin V after sorting due to reduction of the extracellular Ca2+
concentration and thus annexin V does not affect the subsequent incubation with MDM. g Percentage of viable neutrophils that become apoptotic,
as measured by either (i) annexin V+ or (ii) activation of caspase 3/7, over the period of a 6 h co-culture with MDM and LPS (1 ng/ml; n= 6). All n-
numbers represent data derived from separate healthy donors with data plotted as mean ± s.e.m. Neutrophil to MDM or monocyte ratio in co-
cultures were 3:1, unless otherwise stated. Image scale bars= 10 μm. ***P > 0.001, **P > 0.01, *P > 0.05 using paired t-test (a–d) or ANOVA with Tukey
post-hoc test (f). Ct Control, MDM monocyte derived macrophage, A-N apoptotic neutrophil, V-N viable neutrophil, Mono monocyte
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in macrophages; IL-1R and TNFR1. MDM release of
CXCL-8 following treatment with either IL-1β or TNF
was suppressed following co-culture with apoptotic or
viable neutrophils (Fig. 2b, c). These data demonstrate
that apoptotic and viable neutrophils regulate macro-
phage cytokine production through a common mechan-
ism to a range of pro-inflammatory agonists.
The neutrophil-mediated repression of inflammatory
cytokines in MDM is linked to a rapid reduction of NF-κB
activation
NF-κB is involved in the downstream signalling via
TLR-4, IL-1R and TNFR1 and subsequent transcriptional
regulation of the inflammatory cytokines that were sup-
pressed following co-culture of macrophages with neu-
trophils. We therefore investigated the impact of
apoptotic and viable neutrophils on the activation of NF-
κB activation in MDM by assessing the changes in the
phosphorylation status of p65. Using a quantitative flow
cytometric assay, we could demonstrate that LPS induced
an increase in phosphorylated p65 (P-p65) at serine 529
for the entire MDM population (see representative his-
tograms comparing unstimulated (blue) and LPS-
stimulated (red) cells; Fig. 3a–i). This effect was rapid,
with increased levels of P-p65 seen within 30min. How-
ever, for MDM incubated with either apoptotic
(Fig. 3a–ii) or viable neutrophils (Fig. 3a–iii), no increase
in P-p65 fluorescence was observed following LPS treat-
ment. Quantification of the geometric mean fluorescence
for unstimulated and LPS-stimulated MDM populations
revealed that LPS induced a ~6-fold increase in the levels
of P-p65 which was inhibited by ~90% in the presence of
either apoptotic or viable neutrophils (Fig. 3a–iv). More-
over, these data clearly demonstrate that co-incubation
with neutrophils acted to rapidly (<30 min) suppress
NF-κB activation across the entire population rather than
any particular subset of MDM. Immunoblot analysis
confirmed the reduction of P-p65 at serine 529 and show
that P-p65 at serine 536 was also reduced following
neutrophil co-culture, whilst P-p65 at serine 276 was
unaffected (Fig. 3a–v). Phosphorylation of p65 at serines
529 and 536 is critical for nuclear translocation of NF-
κB14–16. Consistent with this, LPS-driven nuclear trans-
location of p65 in MDMs was abolished in the presence of
either apoptotic or viable neutrophils as determined by
confocal microscopy (Fig. 3b–i), quantitative high content
imaging (Fig. 3b–i-ii) and immunoblot analysis of nuclear
extracts (Fig. 3b–iii). These data clearly show that the
activation of NF-κB in MDMs was reduced by the pre-
sence of either apoptotic or viable neutrophils. We then
assessed the level of p65 bound to the TNF promoter by
chromatin immunoprecipitation (ChIP) to determine the
relationship between NF-κB activity and the reduction in
the release of inflammatory cytokines (Fig. 3c). This
analysis demonstrated that the level of p65 bound at the
TNF promoter induced by LPS was significantly reduced
by the presence of either apoptotic or viable neutrophils
(Fig. 3c). Consistent with the MDM model, this
neutrophil-induced suppression of NF-κB activation was
also seen in primary human alveolar macrophages (AM;
Fig. 3d).
Phagocytosis of apoptotic cells is believed to be an
important step in macrophage reprogramming. However,
viable neutrophils are not phagocytosed and MDM
co-incubated with apoptotic neutrophils labelled with
CellTracker Green and the pH sensitive pHrodo RED (to
indicate phagolysosme pH) show less than 20% phago-
cytosis by 40 min (Fig. 3e), markedly contrasting the
abolition of NF-κB phosphorylation in ~90% MDM fol-
lowing 30 min of co-culture (Fig. 3a). To establish if
contact was required for neutrophils to supress the
inflammatory mediator production from macrophages, or
if released mediators were responsible, macrophages were
treated with supernatant from viable and apoptotic-MDM
co-culture. The supernatant suppressed the release of
TNF from MDM to an extent that was comparable with
co-culture. The suppression of TNF release by super-
natants was abolished by ultracentrifugation (Fig. 3f),
indicating that larger extracellular vesicles and/or med-
iator complexes were responsible rather than soluble
mediators such as TGFβ which has previously been pro-
posed to play a role5. Indeed, the levels TGFβ were
unchanged by ultracentrifugation and the addition of
exogenous TGFβ had no significant impact on LPS-
induced release of TNF from MDMs (supplementary data
fig. 4). These data, along with several previous studies17,18,
suggest that TGFβ alone does not induce this suppression.
Importantly, supernatant from apoptotic or viable
Fig. 2 Neutrophil-mediated suppression of macrophage
inflammatory cytokine release in response to different
inflammatory signalling. The release of TNF (a), CXCL-8 (b, c) from
MDM co-cultured with neutrophils and stimulated with LPS (1 ng/ml),
TNF (20 ng/ml) and IL-1β (10 ng/ml), respectively, for 6 h. Data derived
from 8 separate healthy donors and plotted as mean ± s.e.m. ***P >
0.001, **P > 0.01, *P > 0.05 using ANOVA with Tukey post-hoc test. Ct
control, A-N apoptotic neutrophil, V-N viable neutrophil
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Fig. 3 The impact of neutrophils on NF-κB activity in MDM. a LPS-induced (1 ng/ml; 20 min) p65 phosphorylation measured by (i-iv) flow
cytometry (serine 529; n= 4) and (v) immunoblotting (serine 536, 529 and 276; n= 3) in MDM co-cultured with apoptotic or viable neutrophils (total
time point: 30 min). b LPS-induced (1 ng/ml; 20 min) p65 nuclear translocation assessed by (i) quantitative high-content imaging and confocal
microscopy (scale bars 100 μm and 7.5 μm, respectively), (ii) quantification of p65 nuclear translocation from high-content imaging (n= 8) and (iii)
immunoblotting in MDM co-cultured with apoptotic and viable neutrophils (n= 3). Full images of individual stains and merged staining panels are
available in supplemental data (supplemental data Fig. 1). c LPS-induced (1 ng/ml; 1 h) p65 binding to the TNF promotor in MDM co-cultured with
apoptotic or viable neutrophils (n= 3). d LPS-induced (1 ng/ml; 20 min) p65 phosphorylation in alveolar macrophages (n= 3). e Phagocytosis of
apoptotic neutrophils labelled with CellTracker Green and pHrodo Red by MDM at 40 min of co-culture in the presence of LPS (1 ng/ml; n= 14). f
LPS-induced (1 ng/ml; 6 h) TNF release from MDM co-incubated with either apoptotic or viable neutrophils (cells), the supernatants from apoptotic or
viable neutrophils cultured alone for 6 h (Sup) or the supernatants from apoptotic or viable neutrophils co-cultured with MDM for 6 h before
(CoC-Sup) or after (CoC-Sup (UC) ultracentrifugation at 100,000 g for 1 h (n= 4). All n-numbers represent data derived from separate healthy donors
with data plotted as mean ± s.e.m. ***P > 0.001, *P > 0.05 using paired t-test. A-N apoptotic neutrophil, V-N viable neutrophil, ser serine,
Ct control, Nuc nuclear, Cyt. Ext. Ct cytoplasmic extract control, AM alveolar macrophage
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neutrophils alone had no significant effect (Fig. 3f).
Together, these data suggest that neither phagocytosis nor
soluble mediators account for the inhibition of NF-κB or
the subsequent release of TNF induced by either apop-
totic or viable neutrophils. Instead, it is likely that the
release of extracellular vesicles and/or mediator com-
plexes upon co-culture of MDM and neutrophils is
required. These data identify a direct link between a rapid
suppression of NF-κB activation and the reduction in
LPS-induced release of inflammatory cytokines from
MDM by apoptotic and viable neutrophils which is
independent of phagocytosis.
The neutrophil-induced suppression of macrophage NF-κB
activation and inflammatory cytokine release is sustained
Our data demonstrate that viable neutrophils have the
potential to modulate monocyte and macrophage
inflammatory functions during the early phases of
inflammation. However, during the later stages of
inflammation, the interaction between macrophages and
apoptotic cells will predominate, representing a pivotal
step in reprogramming macrophages towards an anti-
inflammatory phenotype8. To address the key question of
whether the modulation of macrophage cytokine profile
represents a transient or sustained alteration in macro-
phage behaviour, MDM were co-cultured with apoptotic
neutrophils for 20 h prior to the removal of non-
internalised cells (Fig. 4a). The release of inflammatory
cytokines was then measured at different time points over
a period of 72 h. Our data show that suppression of TNF
release in response to TLR4 signalling was maintained for
at least 72 h (Fig. 4b). Similarly, suppression of both IL-1R
and TNFR1-induced cytokines was also sustained (Fig 4c,
d), which effect was mirrored by prolonged suppression of
p65 phosphorylation (Fig. 4e). Furthermore, sustained
suppression of NF-κB activation and TNF release by
apoptotic neutrophils was also observed in AM (Fig. 4f),
demonstrating that the MDM model was reflective of
primary human macrophages.
We next determined whether a footprint of the apop-
totic neutrophil-induced alteration in NF-κB signalling
occurred at the transcriptional level. Gene set enrichment
analysis (GSEA) of Affymetrix Human Gene 2.1 ST array
demonstrated that MDM co-cultured with apoptotic
neutrophils have a significant reduction in the gene sets
associated with the activation, nuclear translocation and
transcriptional activity of NF-κB (Fig. 4g–i). Hierarchical
clustering of all the genes contained within these NF-κB
pathway gene sets outlines the differences in gene
expression induced by LPS in MDM co-cultured with or
without apoptotic neutrophils (Fig. 4g–ii). Together, these
data suggest that attenuated activation of NF-κB signal-
ling is responsible for both the rapid and sustained sup-
pression of inflammatory cytokine release induced by
neutrophils and that this occurs at both at the tran-
scriptional and post-transcriptional level which may be an
important contributor to the anti-inflammatory repro-
gramming of macrophages.
Neutrophil-induced suppression of TAK1-IKKβ attenuates
NF-κB activation
The phosphorylation of p65 at serine 536 is critical for
the activation of NF-κB which is in turn facilitated by
several upstream kinases, most prominent of which is
IKKβ14,19. Inhibition of IKKβ using the selective IKKβ
inhibitor TPCA-120 suppressed the release of TNF
(Fig. 5a–i), reduced P-p65 at serine 536 (Fig. 5a–ii) and
inhibited the nuclear translocation of p65 (Fig. 5a–iii) in
response to LPS. The manner in which p65 is suppressed
in macrophages by direct inhibition of IKKβ is similar to
that seen upon co-culture with neutrophils. We therefore
examined the impact of neutrophil co-culture on the
activation of IKKβ in macrophages. Data shown in Fig. 5
demonstrate that both viable and apoptotic neutrophils
potently block the phosphorylation of IKKβ in MDM
(Fig. 5b–i) and, importantly, that blockade of IKKβ acti-
vation is sustained in both MDM (Fig. 5b–ii) and in AM
(Fig. 5b–iii) for at least 24 h, paralleling the sustained
suppression of NF-κB (Fig. 4e-g). Thus, the inhibition of
IKKβ likely represents a pivotal effector in the neutrophil-
induced rapid and sustained blockade of NF-κB activation
and inflammatory cytokine release from macrophages.
Phosphorylation of IKKβ is directly mediated by the
transforming growth factor beta-activated kinase 1
(TAK1), which links the TLR4, IL-1R and TNFR1
receptor-associated complexes with IKKβ and its down-
stream effectors21. Our data show that both apoptotic and
viable neutrophils induce a rapid reduction in the phos-
phorylation of TAK1 in MDM during co-culture
(Fig. 5c–i). The neutrophil-induced blockade in the
phosphorylation of TAK1 was sustained in both MDM
and AM (Fig. 5c–ii-iii), consistent with the observed
sustained suppression of IKKβ (Fig. 5b–ii-iii) and NF-κB
(Fig. 4e-g). Together, these data show that neutrophils
induce a rapid and sustained inhibition of the TAK1-IKKβ
axis (Fig. 5d), representing a central mechanism by which
neutrophils facilitate anti-inflammatory reprogramming
in macrophages.
Discussion
Our study shows that both apoptotic and viable neu-
trophils signal through a common molecular pathway to
influence the cytokine profile of macrophages. Central to
this mechanism is a direct suppression of NF-κB activa-
tion in the macrophage. This reduces the production of
pro-inflammatory cytokines such as TNF, CXCL-8 and
IL-6 which neutrophils are able to affect across mono-
cytes, as well as classically and non-classically activated
Marwick et al. Cell Death and Disease  (2018) 9:665 Page 6 of 13
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Fig. 4 (See legend on next page.)
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macrophage phenotypes. Our data indicate that one of the
mechanisms by which neutrophils induce this inactivation
of macrophage NF-κB is through blockade of the
upstream TAK1-IKKβ signalling axis (Fig. 6). TAK1 is the
kinase subunit of the TRAF6-regulated IKK activator 2
(TRIKA2) complex22, which along with the regulatory
TAB1/2 subunits forms a bridge between activated
inflammatory receptors such as TLR4/IL-1R (viaTRAF6),
TNFR1 (via receptor interacting protein (RIP) 1) and the
IKK complex22,23. TAK1 directly phosphorylates IKKβ,
(see figure on previous page)
Fig. 4 Sustained influence of apoptotic neutrophils on the macrophage cytokine profile. aWork flow for MDM and AM culture and stimulation
post co-culture (pMDM and pAM, respectively). b LPS-induced (1 ng/ml, 6 h) TNF release from pMDM at 0, 24, 48 and 72 h (n= 6). c, d Release of
CXCL-8 (c) and TNF (d) from pMDM stimulated with TNF (20 ng/ml) and IL-1β (10 ng/ml), respectively, for 6 h at 0 or 24 h (n= 4). e high-content
imaging (i; scale bar 100 μm) and quantification (ii, n= 6) of p65 translocation in pMDM stimulated with LPS (1 ng/ml, 1 h) at 0 h and 24 h,
(iii) LPS-induced (1 ng/ml, 30 min) p65 phosphorylation (serine 536) in pMDM at 0 h or 24 h (n= 3). Full images of individual stains and merged
staining panels from high content imaging are available in supplemental data (supplemental data Fig. 2). f TNF release (i) and p65 phosphorylation
(serine 536) (ii) from pAM at 0 and 24 h (n= 11 and 3, respectively). g Table (i) of significantly different NF-κB-related pathways (with a frequency
distribution ratio of less than 0.2) identified by gene set enrichment analysis (GSEA) of an affymetrix 2.1 ST array and (ii) Hierarchical clustering of the
combined genes (326) from these significant NF-κB pathways from LPS-stimulated MDM (1 ng/ml; 9 h) cultured with or without apoptotic
neutrophils (n= 4). All n-numbers represent data derived from separate healthy donors with data plotted as mean ± s.e.m. ***P > 0.001, **P > 0.01
using paired t-test. A-N apoptotic neutrophil, pMDM MDM post co-culture with apoptotic neutrophils, pAM AM post co-culture with apoptotic
neutrophils, Ct control, h hour
Fig. 5 Neutrophil-mediated regulation of TAK1 and IKKβ activation in macrophages. a Inhibition of LPS-induced (1 ng/ml) TNF release (n= 6)
(i), IKKβ and p65 (serine 536) phosphorylation (n= 3) (ii) and p65 translocation (n= 7; scale bar 100 μm) (iii) in MDM using the IKKβ selective inhibitor
TPCA-1. Full images of individual stains and merged staining panels from high content imaging are available in supplemental data. b LPS (1 ng/ml;
20 min) induced IKKβ phosphorylation in MDM co-cultured with apoptotic and live neutrophils (i) and in pMDM (ii) and pAM (iii) at 0 h or 24 h (n= 3).
c LPS (1 ng/ml; 20 min) induced TAK1 phosphorylation in MDM co-cultured with apoptotic and live neutrophils (i) and in pMDM (ii) and pAM (iii) at 0
h or 24 h (n= 3). d Summary flow diagram of proposed inhibition of NF-κB activity in macrophages by neutrophils. All n-numbers represent data
derived from separate healthy donors with data plotted as mean ± s.e.m. ***P > 0.001 using paired t-test. Conc. Concentration, A-N apoptotic
neutrophil, V-N viable neutrophil, Ct Control, h hour
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which in turn activates NF-κB by inducing IκB degrada-
tion and directly phosphorylating p65 at serine 53621
which resides within the C-terminal transactivational
domain (Fig. 6). P65 phosphorylation is central to NF-κB-
mediated gene transcription through facilitating sub-
sequent regulatory modifications such as acetylation24
nuclear translocation25 and binding to the transcriptional
co-activator p30024. Therefore, inhibition of TAK1-IKKβ
activation in macrophages by neutrophils is likely crucial
to the observed abolition of p65 phosphorylation at serine
536 and the subsequent reduction in NF-κB-mediated
gene transcription of pro-inflammatory cytokines.
Our studies also demonstrate several important
mechanistic insights. First, NF-κB-mediated suppression
is induced by either viable or apoptotic neutrophils
ensuring that regulatory effects on macrophage inflam-
matory function occurs independently of changes in
neutrophil viability associated with progression of the
inflammatory response. This suggests that neutrophils
regulate the monocyte and macrophage inflammatory
responses from the earliest stages of their recruitment
through to the ultimate resolution of inflammation
(Fig. 7). Second, we identify a blockade in TAK1-IKKβ-
NF-κB activation as a nodal point for neutrophil-mediated
control of several inflammatory signalling pathways in
macrophages. This provides an important mechanism of
regulating macrophage function in either infectious or
sterile inflammatory microenvironments where multiple
pro-inflammatory signals may be present. Third, we
demonstrate that the suppression of TAK1-IKKβ-NF-κB
signalling and the consequent inflammatory cytokine
release is sustained with a footprint at the transcriptional
level is also significant. One implication is that neutrophil-
mediated regulation of NF-κB activation in macrophages
forms an important part of macrophage anti-inflamma-
tory/pro-resolving reprogramming (Fig. 7). Furthermore,
reduction in the phosphorylation of serine 529 on p65
(Fig. 3), indicates that non-canonical pathways such as
those that signal through casein kinase II15 are also
modulated by neutrophils to suppress NF-κB activation in
macrophages. The existence of multiple regulatory path-
ways would be significant; providing a broad repertoire for
counter-regulation of the activation of NF-κB in macro-
phages by neutrophils and again, highlighting the
importance of controlling NF-κB activation for
anti-inflammatory/pro-resolving reprogramming in
macrophages26.
Although the mechanism by which neutrophils exert
control over the activation of NF-κB and subsequent anti-
inflammatory reprogramming in macrophages remains
unclear, our observations eliminate some possibilities.
First, the rapid suppression of NF-κB in the entire mac-
rophage population rules out a role for post-phagocytosis
events. In the time frame covering the suppression of
NF-κB, there is no significant internalisation of apoptotic
Fig. 6 Canonical activation of NF-κB through the TAK1-IKKβ-NF-
κB axis. Adaptor proteins are recruited to the cell surface receptors
upon its activation. These include the E3 ubiquitin ligase TRAF6 (in the
case of TRL4 and IL-1R) and TRAF2/RIP1 (in the case of TNFR1)
resulting the formation of non-degradative ubiquitin chains on which
TAK1/TAB and IKK complexes are recruited. TAK1 phosphorylates IKKβ
which then induces IκB degradation and phosphorylates p65 at serine
536 resulting in NF-κB transactivation and inflammatory gene
transcription
Fig. 7 Neutrophil-mediated modulation of monocyte and
macrophage mediator profile influences inflammatory control
and resolution. Recruitment of neutrophils to the site of injury during
an innate inflammatory response has the potential to influence the
inflammatory function of recruited monocyte and macrophage
populations. These interactions will control the intensity of the
inflammatory response. Neutrophils undergoing apoptosis will further
regulate responses of monocyte and macrophage populations and
drive sustained anti-inflammatory reprogramming, which is pivotal for
inflammation resolution and tissue repair
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neutrophils by macrophages and even less so by mono-
cytes. Although it is conceivable that the small population
of macrophages which have phagocytosed relay a sup-
pressive signal to the surrounding populations, viable
neutrophils (which are not internalised) induce equivalent
suppression of NF-κB and inflammatory mediator release.
We therefore suggest that phagocytosis of apoptotic cells
is not required for the observed early suppression of NF-
κB, although a role cannot be ruled out for the sustained
response. Second, the suppression of TNF release by
neutrophil-MDM co-culture supernatants, which is
abolished by ultracentrifugation, indicates a requirement
for complexes of mediators and/or released extracellular
vesicles. Microvesicles released from viable neutrophils
exert immunosuppressive activity in vitro27–29 and
in vivo9 when highly concentrated and display several
phenotypes30. However, our observations suggest that
two-way communication between the macrophage and
neutrophil is required to induce release of the required
mediators. Further detailed studies are needed to define
whether cell-cell contact is required for the release of
these mediators and the repertoire of receptors/signalling
involved. It is also interesting to note that, as with the
downstream control of the NF-κB and subsequent
alteration in cytokine profile, this requirement of
neutrophil-macrophage communication and subsequent
vesicle/complex release is independent of apoptosis.
Moreover, other mediators including IL-106, TGFβ5 and
Resolvins7 also have a significant impact on macrophage
anti-inflammatory reprogramming and are release upon
neutrophil-macrophage interactions. Although ultra-
centrifugation rules out their direct role for the initial
suppression of macrophage NF-κB and inflammatory
cytokine release these, in combination with released
extracellular vesicles, are likely required to orchestrate a
spatial and temporal control of the monocyte/macro-
phage inflammatory phenotype to achieve appropriate
reprogramming.
In summary, our data demonstrate a common NF-κB-
dependent mechanism by which neutrophils are able to
modulate monocyte and macrophage function. Dysregu-
lation of such powerful anti-inflammatory signals are
certain to contribute to the pathogenesis of disease via the
accumulation of dysfunctional macrophages and the
propagation of non-resolving inflammation. Indeed, ele-
vated and prolonged activation of NF-κB in macrophages
is seen in a number of chronic inflammatory diseases such
as chronic obstructive pulmonary disease31,32 and severe
asthma33,34 and is likely to contribute to the breakdown in
inflammatory control. Our study identifies a nodal point
in intracellular signalling that could be targeted to bypass
the ‘broken’ sections of the signalling and restore the
resolution phenotype of dysfunctional macrophages to
provide inflammatory control and a pro-resolving
microenvironment necessary for inflammation resolu-
tion and tissue repair.
Materials and Methods
Isolation of neutrophils, monocytes and alveolar
macrophages
Peripheral venous blood was taken from healthy human
volunteers in accordance with local ethics (AMREC 15-
HV-013). Granulocytes and mononuclear cells were iso-
lated from the blood using discontinuous percol gradients
as previously described35. Granulocytes were 90–95%
neutrophils with 5–10% eosinophils as assessed by mor-
phology using cytocentrifuation preparation followed by
staining with Diff-Quik (Gentaur Molecular Products)
and are referred to throughout the study as neutrophils.
Monocytes were purified from the mononuclear cells
using a pan monocyte isolation kit (Miltenyi Biotec) and
washed 40 min after adhesion to further purify the
population from residual lymphocyte and platelet con-
tamination. Alveolar macrophages (AM) and neutrophils
were isolated by cell sorting the bronchoalveolar lavage
from patient’s undergoing bronchoscopy in accordance
with local ethics (AMREC 07/S1102/20; see supplemen-
tary data table 1 for patient details).
Cell culture
Monocytes were cultured in IMDM (Gibco) with 2%
autologous human AB serum (AS; Sigma Aldrich) over-
night before use. MDM were generated by culturing the
monocytes for 5 days in IMDM (2% AS) with 5 ng/ml
GM-CSF and 20 ng/ml IL-6 (R&D Systems) to drive dif-
ferentiation into a macrophage phenotype36. During this
period, no media was removed, but an additional volume
of fresh media (25% of the total volume) containing 2% AS
but no cytokines was added on day 3. To induce inflam-
matory MDM, INFγ (20 ng/ml; R&D Systems) was added
24 h before assay. Immediately before assay the cells are
washed with HBSS (Gibco). AM were cultured in IMDM
with 2% AU for a minimum of 2 days before treatment.
Live neutrophils (from both blood and BAL) were re-
suspended in IMDM without serum and used immedi-
ately in the appropriate co-culture assay. BL2 Burkitt’s
lymphoma cells and Jurkat cells were cultured in RPMI
(Gibco) with 10% heat inactivated foetal calf serum
(hiFCS; Gibco) and maintained at a density of 0.3–1
million per ml. All cells were cultured using standard
culture conditions: 37 degrees with 5% CO2.
Induction of apoptosis
Neutrophils were cultured overnight in IMDM with 1%
BSA (Sigma). BL-2 and Jurkat cells were exposed to UV
(CL-1000 Ultraviolet Crosslinker; Ultra-Violet Products
Ltd) at 300mJ/cm2 and cultured for a further 4 h.
Apoptosis was assessed by morphological assessment using
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cytocentrifugation preparations stained with Diff-Quik and
flow cytometry (see below).
Co-Culture, supernatant and phagocytosis assay
Apoptotic and viable target cell preparations were
washed 2 times in HBSS (Gibco) with 2 mM EDTA
(Gibco) and then re-suspended in IMDM without serum
at the appropriate concentration. Monocyte or MDM
cultures were washed in once with HBSS. The apoptotic
or viable target cells were added to the monocyte/MDM
cultures at a ratio of 3 to 1 for 10min (unless otherwise
stated) in serum free IMDM, followed by LPS stimulation
(Escherichia coli O127:B8; Sigma) for the time stated.
Where co-culture was for more than 6 h, hiFCS was added
to 0.5% at 8 h and maintained for the duration of the
assay. For stimulation with TNF or IL-1β (R&D Systems)
during co-culture, 0.5% hiFCS was added with TNF/IL-1β.
Co-culture supernatants were generated by co-culture
of the MDM and neutrophils as described but without
LPS. For neutrophils mono-culture, live or apoptotic
neutrophils were plated in the same media, at the same
density and in the same 96 well culture plate type (Falcon,
353072) as for the co-culture assay. The co- and mono-
cultures were maintained for 6 h to mimic the standard
co-culture assay time. After 6 h, the supernatants were
removed and centrifuged at 300 g for 5 min to remove any
cells or cell debris. For ultracentrifugation, the samples
were spun at a further 100,000×g for 2 h (Beckman
Optima TLX Ultracentrifuge). All supernatants were then
added to the MDM and assayed for 6 h with or without
LPS.
For phagocytosis, apoptotic neutrophils were labelled
with CellTracker Green (Invitrogen) and pHrodo Red
(Invitrogen). The labelled apoptotic neutrophils were then
co-cultured with MDM at a ratio of 3:1 for 40min at 37 °C
with LPS (1 ng/ml). The co-cultures were then washed 3
times with HBSS prior to detachment of the cells with
trypsin/EDTA and flow cytometric analysis (see below).
Flow cytometry and cell sorting
Apoptosis was determined by flow cytometry (BD
Biosciences LSR Fortessa) with cells stained for annexin
IV-APC (BD Biosciences), propidium iodide (Sigma
Aldrich) or active caspase 3/7 (CellEvent; Molecular
Probes) and counter stained with Hoechst 3342 (NucBlue;
Molecular Probes). Isolation of cell populations was per-
formed using cell sorting (BD Biosciences FACs Aria II).
BAL cells were stained with anti-HLA-DR V450, anti-CD-
16 PE and CD3-FITC (BD Biosciences). AM were isolated
by forward/side scatter gating on the HLA-DR positive
population. Neutrophils were gated on CD16 positive cells
which were HLA-DR and CD3 negative. Phagocytosis of
apoptotic neutrophils was determined by flow cytometric
analysis of MDM positive for CellTracker Green and
pHrodo Red (BD Biosciences LSR Fortessa). Analysis of P-
p65 ser529 in MDM by flow cytometry was performed
using BD Biosciences PhosFlow reagents and protocol.
See supplementary data for extended protocol.
ELISA
Supernatants were removed from the cell cultures at the
times indicated, centrifuged at 3800g. for 1 min to remove
cells and subject to either immediate ELSA or stored at
−20 °C until use. All ELISA were performed using DuoSet
Kits (R&D Systems) according to manufacturer’s
instructions. Plates were analysed on a Synergy HT Bio-
tech plate reader using Gen 5 software.
Immunobotting
Lysates were subject to gel electrophoresis using 5–12%
Bis-Tris gels (Invitrogen), transferred to optitran nitro-
cellulaose membranes (Sigma) and blocked in TBS-0.1%
tween with 5% non-fat dried milk. Primary antibodies were
probed overnight in TBS-0.1% Tween containing 5% BSA
with secondary antibodies probed in TBS-0.1% Tween
containing 5% non-fat dried milk for 1 h. Immunoblots
were developed using ECL prime (GE Life Sciences) on
CL-XPosure film (Sigma) using an EcomaxProtec devel-
oper (Photon Imaging Systems). See supplementary
materials and methods for extended protocol including
cell lysis. Antibodies list: anti-P-p65 ser536 (#3031), anti-
P-IKKα/β (#2697), anti-IKKβ (#8943), anti-P-TAK1
(#4508) and anti-TAK1 (#5206) were purchased from
Cell Signalling Technology. Anti-p65 (Santa Cruz Bio-
technology: sc-372), Anti-P-p65 ser529 (eBioscience: 14-
9864-82), anti-P-p65 ser276 (Millipore: AB3375), anti-
GAPDH (Sigma: G9295) and anti-β-Actin (Sigma: A1978).
Goat anti-rabbit (P0448) and goat anti-mouse (P0447)
secondary antibodies were purchased from Dako.
ChIP assay
ChIP assays were performed using EZ Magna ChIP Kits
(Millipore) according to the manufacturer’s instructions.
Cells were fixed using 1% methanol free formaldehyde
(Pierce; ThermoFischer Scientific) and subject to sonica-
tion for 10 cycles of 15 s (Soniprep 150; MSE). IP was
performed using the ChIPAb+NF-κB p65 antibody
(Millipore) and qPCR performed using ChIP-qPCR Pri-
mer Assay for Human TNF (SABiosciences) with SYBR
Green qPCR master mix (SABiosciences) and ran on a
7900HT Fast RT-PCR System (Applied Biosystems) with
analysis performed using Applied Biosystems SDS
2.4 software.
Immunocytochemistry
Staining for p65 was performed using a modified pro-
tocol from Blaecke A. et al37 using Lab-Tek chamber
slides (Nunc; Sigma) for confocal microscopy, or 96 well
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optical image plates (Greiner) for high content imaging.
Cells were fixed with 4% PFA (Sigma), permeabilised with
methanol then stained with anti-p65 antibody (sc-372-G;
Santa Cruz Biotechnology), Donkey anti-Goat IgG AF647
(Molecular probes A-21447), Hoechst 33342 (NucBlue;
Molecular Probes) and phalloidin (Molecular Probes).
Confocal microscopy was performed using a Zeiss
LSM510 META and high content imaging performed
using an ImageXpress XLS Widefield High-Content
Analysis System (Molecular Devices) with MetaXpress
analysis. See supplementary data for extended protocol.
Gene array
Cells were washed with ice cold PBS, incubated in
scrape buffer (see immunoblotting) for 10 min before
being scraped then pelleted at 300×g for 5 min at 4 °C.
RNA extraction was performed using RNeasy Mini Kits
(Qiagen) according to the manufacturer’s instructions. An
Affimetrix human genome U219 array was performed by
Edinburgh Genomics (https://genomics.ed.ac.uk/) with
Partek Software analysis. The data discussed in this pub-
lication have been deposited in NCBI’s Gene Expression
Omnibus (GEO) and are accessible through GEO Series
accession number GSE90010 (http://www.ncbi.nlm.nih.
gov/geo/query/acc.cgi?acc=GSE90010).
Data analysis
Comparison of multiple treatment groups was per-
formed using one-way ANOVA with Tukeys post-hoc
test, comparisons between two treatment groups was
performed using paired student’s t-test and the data
presented as the mean ± s.e.m. Analysis was performed
using GraphPad Prism Software.
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